Growth Metrics

Gsk (GLAXF) Asset Writedowns and Impairment (2016 - 2017)

Historic Asset Writedowns and Impairment for Gsk (GLAXF) over the last 2 years, with Q4 2017 value amounting to -$228.4 million.